Skip to main content

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q1 2024

Institutional positions in Esperion Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
152
+21 vs. Q4 2023
Shares held
125.5M
+53.5M (+74.5%) vs. Q4 2023
Total value
$336.2M
+$120.9M (+56.2%) vs. Q4 2023
New holders
43
48 more added
Sold out
22
28 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ESPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 152 institutions
Q1 2021: 156 institutionsQ2 2021: 142 institutionsQ3 2021: 139 institutionsQ4 2021: 133 institutionsQ1 2022: 132 institutionsQ2 2022: 137 institutionsQ3 2022: 148 institutionsQ4 2022: 164 institutionsQ1 2023: 165 institutionsQ2 2023: 124 institutionsQ3 2023: 123 institutionsQ4 2023: 132 institutionsQ1 2024: 152 institutionsQ2 2024: 176 institutionsQ3 2024: 184 institutionsQ4 2024: 190 institutionsQ1 2025: 187 institutionsQ2 2025: 164 institutionsQ3 2025: 189 institutionsQ4 2025: 201 institutionsQ1 2026: 207 institutionsQ2 2026: 191 institutions
Value heldQ1 2024: $336.2M
Q1 2021: $805.3MQ2 2021: $599.4MQ3 2021: $299.4MQ4 2021: $268.0MQ1 2022: $241.2MQ2 2022: $352.1MQ3 2022: $425.5MQ4 2022: $457.6MQ1 2023: $129.1MQ2 2023: $103.6MQ3 2023: $75.9MQ4 2023: $215.3MQ1 2024: $336.2MQ2 2024: $304.2MQ3 2024: $214.3MQ4 2024: $277.9MQ1 2025: $171.5MQ2 2025: $96.6MQ3 2025: $286.1MQ4 2025: $559.6MQ1 2026: $479.3MQ2 2026: $646.8M
Institutions holding ESPR and their total value by quarter
QuarterHoldersValue
Q2 2026191$646.8M
Q1 2026207$479.3M
Q4 2025201$559.6M
Q3 2025189$286.1M
Q2 2025164$96.6M
Q1 2025187$171.5M
Q4 2024190$277.9M
Q3 2024184$214.3M
Q2 2024176$304.2M
Q1 2024152$336.2M
Q4 2023132$215.3M
Q3 2023123$75.9M
Q2 2023124$103.6M
Q1 2023165$129.1M
Q4 2022164$457.6M
Q3 2022148$425.5M
Q2 2022137$352.1M
Q1 2022132$241.2M
Q4 2021133$268.0M
Q3 2021139$299.4M
Q2 2021142$599.4M
Q1 2021156$805.3M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Esperion Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding ESPR in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Barclays PLC104,484$280.0K0.00%−16,600−13.7%Reduced
FMR LLC105,171$281.9K0.00%−171,675−62.0%Reduced
Point72 Asia (Singapore) Pte. Ltd.114,371$306.5K0.08%+94,171+466.2%Added
Group One Trading, L.P.120,759$323.6K0.01%+120,759New
UBS Oconnor LLC142,418$381.7K0.01%−384,705−73.0%Reduced
Balyasny Asset Management LLC159,038$426.2K0.00%+121,850+327.7%Added
Susquehanna Fundamental Investments, LLC166,457$446.1K0.02%+166,457New
Marathon Trading Investment Management LLC170,500$456.9K0.18%+149,500+711.9%Added
Marex Group plc175,000$469.0K0.02%+25,000+16.7%Added
HighTower Advisors, LLC187,166$496.0K0.00%+137,597+277.6%Added
NJ State Employees Deferred Compensation Plan195,125$522.9K0.07%00.0%Unchanged
Davidson Kempner Capital Management LP222,482$594.0K0.01%00.0%Unchanged
Walleye Capital LLC227,630$610.0K0.01%+13,630+6.4%Added
Parallel Advisors, LLC239,000$640.5K0.02%−239,000−50.0%Reduced
Cubist Systematic Strategies, LLC273,292$732.4K0.01%+88,321+47.7%Added
Pinnacle Associates Ltd285,204$764.3K0.01%+1,949+0.7%Added
Squarepoint Ops LLC300,300$804.8K0.00%+212,588+242.4%Added
Northern Trust Corp308,677$827.3K0.00%+72,084+30.5%Added
Citigroup Inc356,748$956.1K0.00%−21,243−5.6%Reduced
Wellington Management Group LLP360,827$967.0K0.00%+360,827New
Man Group plc440,770$1.18M0.00%+223,785+103.1%Added
HRT Financial LP442,030$1.18M0.01%+394,059+821.5%Added
Gsa Capital Partners LLP449,129$1.20M0.10%−679,020−60.2%Reduced
State Street Corp551,249$1.48M0.00%+167,500+43.6%Added
Jacobs Levy Equity Management, Inc704,097$1.89M0.01%−353,787−33.4%Reduced
Schonfeld Strategic Advisors LLC947,506$2.54M0.02%−143,822−13.2%Reduced
Jane Street Group, LLC983,343$2.64M0.00%+707,696+256.7%Added
Parkman Healthcare Partners LLC1,142,897$3.06M0.38%−282,307−19.8%Reduced
Platinum Investment Management Ltd1,597,542$4.28M0.17%−1,213,013−43.2%Reduced
Qube Research & Technologies Ltd1,607,312$4.31M0.01%+1,172,071+269.3%Added
Morgan Stanley1,642,360$4.40M0.00%+537,360+48.6%Added
Geode Capital Management, LLC1,753,193$4.70M0.00%+640,947+57.6%Added
Susquehanna International Group, LLP2,045,769$5.48M0.01%+655,495+47.1%Added
JPMorgan Chase & Co2,085,101$5.59M0.00%+222,631+12.0%Added
Renaissance Technologies LLC2,116,500$5.67M0.01%+696,400+49.0%Added
Marshall Wace, LLP2,215,961$5.94M0.01%+1,758,203+384.1%Added
BlackRock Inc.2,838,820$7.61M0.00%+725,921+34.4%Added
Citadel Advisors LLC3,362,210$9.01M0.01%+2,899,928+627.3%Added
Goldman Sachs Group Inc3,364,266$9.02M0.00%+2,306,865+218.2%Added
Two Sigma Advisers, LP3,569,700$9.57M0.02%+1,423,100+66.3%Added
Meditor Group Ltd3,791,300$10.2M14.93%00.0%Unchanged
Two Sigma Investments, LP3,975,560$10.7M0.03%+1,641,150+70.3%Added
Two Seas Capital LP4,165,657$11.2M2.19%−3,520,463−45.8%Reduced
Bank of America Corp4,545,260$12.2M0.00%+4,368,724+2,474.7%Added
D. E. Shaw & Co., Inc.5,143,486$13.8M0.02%+3,930,283+324.0%Added
Millennium Management LLC5,681,744$15.2M0.01%+2,232,293+64.7%Added
Woodline Partners LP7,922,229$21.2M0.20%+7,631,847+2,628.2%Added
Great Point Partners LLC8,000,000$21.4M3.34%+8,000,000New
Vanguard Group Inc8,826,546$23.7M0.00%+3,688,796+71.8%Added
Wasatch Advisors Inc9,129,647$24.5M0.13%+238,544+2.7%Added
Bellevue Group AG9,944,064$26.7M0.41%+5,739,800+136.5%Added
OrbiMed Advisors LLC13,708,731$36.7M0.72%+13,708,731New
Armistice Capital, LLC0$00.00%−3,200,000−100.0%Sold out
Tang Capital Management LLC0$00.00%−1,850,000−100.0%Sold out
Whitefort Capital Management, LP0$00.00%−885,522−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−352,054−100.0%Sold out
Ikarian Capital, LLC0$00.00%−337,636−100.0%Sold out
Monaco Asset Management SAM0$00.00%−243,642−100.0%Sold out
Highbridge Capital Management LLC0$00.00%−221,722−100.0%Sold out
Silverback Asset Management LLC0$00.00%−100,000−100.0%Sold out
683 Capital Management, LLC0$00.00%−134,689−100.0%Sold out
Boston Private Wealth LLC0$00.00%−60,554−100.0%Sold out
Engineers Gate Manager LP0$00.00%−52,932−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−42,200−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−41,733−100.0%Sold out
Caption Management, LLC0$00.00%−31,600−100.0%Sold out
Cetera Advisor Networks LLC0$00.00%−12,500−100.0%Sold out
Chicago Partners Investment Group LLC0$00.00%−15,066−100.0%Sold out
Captrust Financial Advisors0$00.00%−10,050−100.0%Sold out
Private Portfolio Partners LLC0$00.00%−10,000−100.0%Sold out
O'Dell Group, LLC0$00.00%−4,500−100.0%Sold out
Headlands Technologies LLC0$00.00%−3,208−100.0%Sold out
Advisory Services Network, LLC0$00.00%−62−100.0%Sold out
TD Waterhouse Canada Inc.0$00.00%−60−100.0%Sold out
Sawtooth Solutions, LLC––––Not filed